Showing 1 - 3 results of 3 for search 'Chris Wynne', query time: 0.01s Refine Results
  1. 1
    Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta® in healthy subjects: A randomized, double‐blind trial

    Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta® in healthy subjects: A randomized, double‐blind trial by Chris Wynne, Christian Schwabe, Emmanuelle Vincent, Armin Schueler, Janka Ryding, Martin Ullmann, Vishal Ghori, Radmila Kanceva, Michael Stahl

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC‐0214 in healthy volunteers

    Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC‐0214 in healthy volunteers by Rui Zhu, Hubert Chen, Joshua Galanter, Gaohong She, Fang Cai, Matthew R. Durk, Yixuan Zou, Liuxi Chen, Jane R. Kenny, Shweta Vadhavkar, Simon Warren, Glyn Taylor, Olivia Hwang, Avi Eliahu, Chris Wynne, Ryan Owen

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers

    First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers by Fei Tang, Rebecca Kunder, Tom Chu, Avis Hains, Allen Nguyen, Jacqueline M. McBride, Yu Zhong, Sara Santagostino, Maria Wilson, Abigail Trenchak, Liuxi Chen, Justin Ly, Anita Moein, Nicholas Lewin‐Koh, Vibha Raghavan, Uyi Osaghae, Chris Wynne, Ryan Owen, David Place

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: